Matthew K. Robinson - Jun 8, 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Technology Officer
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
Jun 8, 2023
Transactions value $
$0
Form type
4
Date filed
6/12/2023, 04:57 PM
Previous filing
Jun 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock Option (Right to Buy) Award $0 +58K $0.00 58K Jun 8, 2023 Common Stock 58K $4.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-forty-eighth (1/48th) of the shares subject to such options shall vest monthly over forty-eight months after the grant date.